Takeda Pharmaceutical (TAK) Profit After Tax (2017 - 2026)
Takeda Pharmaceutical (TAK) posted quarterly Profit After Tax of $710.6 million for Q2 2026, down 17.27% year-over-year from $858.9 million in Q2 2025, and down 10.35% quarter-over-quarter from $792.6 million in Q1 2026.
Takeda Pharmaceutical (TAK) Profit After Tax (2017 - 2026) Analysis & Trends
Takeda Pharmaceutical's Profit After Tax history runs 10 years deep, the most recent figure standing at $710.6 million for Q2 2026.
- In Q2 2026, Profit After Tax fell 17.27% year-over-year to $710.6 million; the TTM figure through Jun 2026 stood at $577.3 million (down 76.06% YoY), while the FY2026 annual figure was -$1.0 billion, down 242.35% from the prior year.
- Profit After Tax for Q2 2026 stood at $710.6 million, down from $792.6 million in the prior quarter.
- The five-year high for Profit After Tax was $2.0 billion in Q3 2023, with the low at -$2.4 billion in Q4 2025.
- The 5-year median for Profit After Tax is $793.2 million (2023), against an average of $620.4 million.
- The sharpest annual moves came in 2023 and 2024: Profit After Tax surged 342.91% in 2023, then slumped 422.33% in 2024.
- Takeda Pharmaceutical's Profit After Tax stood at $843.4 million in 2022, then plunged by 75.05% to $210.4 million in 2023, then tumbled by 422.33% to -$678.2 million in 2024, then slumped by 252.98% to -$2.4 billion in 2025, then jumped by 129.68% to $710.6 million in 2026.
- Business Quant data shows TAK's Profit After Tax at $710.6 million in Q2 2026, $792.6 million in Q1 2026, and -$2.4 billion in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.79 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.38 Bn | 39.73 Bn | 2.15 Bn | -576.00 Mn |
| 3 | Zoetis | 31.61 Bn | 29.93 Bn | 1.05 Bn | 866.00 Mn |
| 4 | Takeda Pharmaceutical | 28.64 Bn | 22.84 Bn | 5.10 Bn | 710.56 Mn |
| 5 | United Therapeutics | 22.20 Bn | 19.54 Bn | 683.80 Mn | 333.00 Mn |
| 6 | Viatris | 18.82 Bn | 17.93 Bn | 1.46 Bn | -118.80 Mn |
| 7 | Neurocrine Biosciences | 15.67 Bn | 15.28 Bn | 935.80 Mn | 149.10 Mn |
| 8 | Elanco Animal Health | 12.11 Bn | 11.58 Bn | 798.00 Mn | 54.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Alkermes | 8.21 Bn | 7.55 Bn | 397.90 Mn | 501,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 710.56 Mn |
| Mar 31, 2026 | 792.61 Mn |
| Dec 31, 2025 | -2.39 Bn |
| Sep 30, 2025 | 1.47 Bn |
| Jun 30, 2025 | 858.91 Mn |
| Mar 31, 2025 | 814.74 Mn |
| Dec 31, 2024 | -678.17 Mn |
| Sep 30, 2024 | 1.42 Bn |
| Jun 30, 2024 | 612.19 Mn |
| Mar 31, 2024 | 643.07 Mn |
| Dec 31, 2023 | 210.40 Mn |
| Sep 30, 2023 | 1.98 Bn |
| Jun 30, 2023 | 652.39 Mn |
| Mar 31, 2023 | 793.80 Mn |
| Dec 31, 2022 | 843.37 Mn |
| Sep 30, 2022 | 446.97 Mn |
| Jun 30, 2022 | 812.06 Mn |
| Mar 31, 2022 | 1.18 Bn |
| Dec 31, 2021 | 508.66 Mn |
| Sep 30, 2021 | 417.81 Mn |